Abstract:Yupeng Han, 1, 2, &ast Liangcheng Qiu, 1, 2, &ast Haixing Wu, 1, 2, &ast Zhiwei Song, 3 Peng Ke, 1, 2 Xiaodan Wu 1, 2 1 Department of Anesthesiology, Fujian Provincial Hospital, Shengli Clinical Medical College of Fujian Medical University, Fuzhou, Fujian, People's Republic of China; 2 Fujian Provincial Key Laboratory of Critical Care Medicine, Fuzhou, Fujian, People's Republic of China; 3 Department of Neurology, Fujian Provincial Hospital, Shengli Clinical Medical College of Fujian Medical University, Fuzhou, Fujian, People's Republic of China &astThese authors contributed equally to this work Correspondence: Xiaodan Wu, Department of Anesthesiology, Fujian Provincial Hospital, Shengli Clinical Medical College of Fujian Medical University, Fuzhou, Fujian, People's Republic of China, Email Sepsis is a severe systemic inflammatory response commonly occurring in infectious diseases, caused by infection with virulent pathogens. In the pathogenesis of sepsis, the cyclic guanosine monophosphate (GMP)-adenosine monophosphate (AMP) synthase-stimulator of interferon genes (cGAS-STING) signaling pathway serves a crucial role as a fundamental immunoregulatory mechanism. This signaling pathway activates STING upon recognizing intracellular DNA damage and pathogen-derived DNA, subsequently inducing the production of numerous inflammatory mediators, including interferon and inflammatory cytokines, which in turn trigger an inflammatory response. The aim of this paper is to explore the activation mechanism of the cGAS-STING signaling pathway in sepsis and its impact on inflammatory regulation. By delving into the mechanism of action of the cGAS-STING signaling pathway in sepsis, we aim to identify new therapeutic strategies for the treatment and prevention of sepsis. Keywords: sepsis, cGAS, STING, inflammation Sepsis is a critical condition characterized by multi-organ dysfunction and potentially leading to organ failure, resulting from an over-activated inflammatory response triggered by infection. Furthermore, host immune dysfunction, attributed to this excessive inflammatory response, is closely associated with increased mortality rates in sepsis patients. 1–3 The excessive inflammatory response and the ensuing cytokine storm have been long identified as primary contributors to the elevated mortality rates among sepsis patients. 4,5 However, recent years have seen that drugs targeting cytokine receptors, including Tumor necrosis factor-α (TNF-α), Interleukin-1β (IL-1β), and others, have failed to significantly improve clinical outcomes in sepsis patients. 6,7 Recent research has elucidated that both innate immune dysfunction and acquired immunosuppression are of equal importance in contributing to the multiorgan failure and mortality associated with sepsis. 8 Consequently, preserving the normal functionality of both innate and acquired immune mechanisms is pivotal for the effective treatment of sepsis. 3,9 In recent years, research into the cyclic guanosine monophosphate (GMP)-adenosine monophosphate (AMP) synthase-stimulator of interferon genes (cGAS-STING) signaling pathway has been extensive, highlighting its critical role in sensing aberrant intracellular DNA and triggering the host's immune response. 10,11 Current research indicates that aberrant activation of this pathway may induce significant production of type I interferon (IFN-I) and other inflammatory cytokines, potentially influencing the onset and progression of the body's inflammatory response. In the pathological context of sepsis, infection-induced cell death or tissue damage results in the release of large amounts of DNA into the cytoplasm, with the activation of the cGAS-STING signaling pathway potentially serving as a crucial regulatory point in the inflammatory response. 12 However, the role of the cGAS-STING signaling pathway in sepsis and its regulatory mechanisms in the pathophysiological process of sepsis development have not been fully elucidated. In this article, we review the current research status of the cGAS-STING signaling pathway in the occurrence and development of sepsis as reported in previous studies. We also explore its application in the treatment of sepsis, aiming to provide valuable insights for future therapeutic strategies and research directions. The cGAS-STING signaling pathway is an important signaling pathway involved in the immune response, initiating the immune response by recognizing aberrant intracellular DNA. Its aberrant activation or dysregulation has been demonstrated to closely associate with the development of various diseases, including infect -Abstract Truncated-

Inhibition of the cGAS-STING Pathway Attenuates Lung Ischemia/Reperfusion Injury via Regulating Endoplasmic Reticulum Stress in Alveolar Epithelial Type II Cells of Rats

Abstract Sa603: Inhibiting the Activation of Cgas-Sting Signaling Pathway Can Improve Brain Injury after Cardiopulmonary Resuscitation

Activating NO–sGC Crosstalk in the Mouse Vascular Niche Promotes Vascular Integrity and Mitigates Acute Lung Injury

The Cgas-Sting Pathway Drives Alveolar Epithelial Cell Death Via Non-Canonical PKR Signaling During Lung Ischemia-Reperfusion Injury

Inhibition of the cGAS-STING pathway: contributing to the treatment of cerebral ischemia/reperfusion injury

Role of the Cgas DNA Sensing Pathway in Acute Intestinal Ischemia-Reperfusion Injury

Stimulator of interferon genes (STING): Key therapeutic targets in ischemia/reperfusion injury

Cgas-Mediated Autophagy Protects the Liver from Ischemia-Reperfusion Injury Independently of STING.

The cGAS-STING Pathway: A New Therapeutic Target for Ischemia-Reperfusion Injury in Acute Myocardial Infarction?

[High STING expression exacerbates renal ischemia-reperfusion injury in mice by regulating the TLR4/NF-κB/NLRP3 pathway and promoting inflammation and apoptosis]

Inhibition of Sirt3 activates the cGAS-STING pathway to aggravate hepatocyte damage in hepatic ischemia–reperfusion injury mice

NETs Promote Inflammatory Injury by Activating cGAS-STING Pathway in Acute Lung Injury

cGAS/STING regulates inflammation of human pulmonary microvascular endothelial cells via NLRP3 inflammasome

GSDMD promotes neutrophil extracellular traps via mtDNA-cGAS-STING pathway during lung ischemia/reperfusion

Dynamic Changes of Pneumocyte Apoptosis and Aspartate-Specific Cysteine Proteases-3 Expression in Rats Subjected to Ischemia/reperfusion Injury in Lung Tissue

The cGAS-STING pathway in ischemia-reperfusion injury in acute cerebral infarction: a new therapeutic opportunities?

SIRT1-Rab7 axis attenuates NLRP3 and STING activation through late endosomal-dependent mitophagy during sepsis-induced acute lung injury

Focus on the cGAS-STING Signaling Pathway in Sepsis and Its Inflammatory Regulatory Effects

Identification of Neutrophil Extracellular Trap-Related Gene Expression Signatures in Ischemia Reperfusion Injury During Lung Transplantation: A Transcriptome Analysis and Clinical Validation

Ginsenoside Rg1 Regulates SIRT1 to Ameliorate Sepsis-Induced Lung Inflammation and Injury via Inhibiting Endoplasmic Reticulum Stress and Inflammation

The protective effect of H151, a novel STING inhibitor, in renal ischemia-reperfusion-induced acute kidney injury